Vitamin D status is categorized based on serum 25 (OH) D levels, and the half-life of the vitamin is approximately 2 - 4 weeks. However, this half-life may be decreased even less than a week in the event of hemodilution, infection, or other catabolic diseases.D Rise is indicated for the treatment of Vitamin D3 (Cholecalciferol) deficiency. Read more about D rise.

1. 1/3
D Rise
d-rise.in

2. 2/3
References
1. Calculated based upon article by Kamboj P et.al (2018) 2. Ann NY Acad Sci May.131792-
8 3. HCP: Cardiologist, Diabetologist, Endocrinologist, Consulting Physician 4. Acute
Respiratory Distress Syndrome 5. Rosas-Peralta, M., Holick, M. F., Borrayo-Sánchez, G.,
Madrid-Miller, A., Ramírez-Árias, E., & Arizmendi-Uribe, E. (2017). Dysfunctional
immunometabolic effects of vitamin D deficiency, increased cardiometabolic risk.
Potential epidemiological alert in America? 6. Grossmann, R. E., & Tangpricha, V. (2010).
Evaluation of vehicle substances on vitamin D bioavailability: a systematic review.
Molecular nutrition & food research, 54(8), 1055–1061.
https://doi.org/10.1002/mnfr.200900578 7. Critical Reviews in Food Science and
Nutrition (2013): Vitamin D bioavailability: State of the art. 8. Nakashima, A., Yokoyama,
K., Yokoo, T., & Urashima, M. (2016). Role of vitamin D in diabetes mellitus and chronic
kidney disease. World journal of diabetes, 7(5), 89–100.
https://doi.org/10.4239/wjd.v7.i5.89 9. Rastogi A, Bhansali A, Khare N, et al Short term,
high-dose Vitamin D Supplementation for COVID-19 disease: a randomised, placebo-
controlled, study (SHADE study) Postgraduate Medical Journal 2022;98:87-90 10.
Jolliffe, D. A., Camargo, C. A., Jr, Sluyter, J. D., Aglipay, M., Aloia, J. F., Ganmaa, D.,
(2020). Vitamin D Supplementation to prevent acute respiratory infections: systematic
review and meta-analysis of aggregate data from randomised controlled trials. medRxiv :
the preprint server for health sciences, 2020.07.14.20152728.
https://doi.org/10.1101/2020.07.14.20152728 11. Rai, V., & Agrawal, D. K. (2017). Role of
Vitamin D in Cardiovascular Diseases. Endocrinology and metabolism clinics of North
America, 46(4), 1039–1059. https://doi.org/10.1016/j.ecl.2017.07.009 12. Sun, X., Cao, Z.
B., Tanisawa, K., Ito, T., Oshima, S., & Higuchi, M. (2016).Vitamin D Supplementation
reduces insulin resistance in Japanese adults: a secondary analysis of a double-blind,
randomized, placebo-controlled trial. Nutrition research (New York, N.Y.), 36(10), 1121–
1129. https://doi.org/10.1016/j.nutres.2016.07.006 13. Wang C. (2013). Role of vitamin d
in cardiometabolic diseases. Journal of diabetes research, 2013, 243934.
https://doi.org/10.1155/2013/243934 14. Khayznikov, M., Hemachrandra, K., Pandit, R.,
Kumar, A., Wang, P., & Glueck, C. J. (2015). Statin Intolerance Because of Myalgia,
Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D
Supplementation. North American journal of medical sciences, 7(3), 86–93.
https://doi.org/10.4103/1947-2714.153919 15. Wang, L. X., Wang, N., Xu, Q. L., Yan, W.,
Dong, L., & Li, B. L. (2017). Effects of vitamin D combined with pioglitazone
hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic
nephropathy. Bioscience reports, 37(2), BSR20160544.
https://doi.org/10.1042/BSR20160544 16. Amin, S. N., Hussein, U. K., Yassa, H. D.,
Hassan, S. S., & Rashed, L. A. (2018). Synergistic actions of vitamin D and metformin on
skeletal muscles and insulin resistance of type 2 diabetic rats. Journal of cellular
physiology, 233(8), 5768–5779. https://doi.org/10.1002/jcp.26300 17. Efficacy of
Vitamin D3 in Patients With Diabetic Nephropathy: An Updated Meta-Analysis Min

3. 3/3
Zhang, Tiejun Liu, Wenge Li, Weijun Gong, Xusheng Yang, and Jianing Xi. 2017 18.
Lancet Diabetes Endocrinol 2021; 9: 837–46 19. Bleizgys A. (2021). Vitamin D and
COVID-19: It is time to act. International journal of clinical practice, 75(3), e13748.
https://doi.org/10.1111/ijcp.13748 20. Nwosu, B. U., Parajuli, S., Jasmin, G., Fleshman,
J., Sharma, R. B., Alonso, L. C., Lee, A. F., & Barton, B. A. (2021). Ergocalciferol in New-
onset Type 1 Diabetes: A Randomized Controlled Trial. Journal of the Endocrine Society,
6(1), bvab179. https://doi.org/10.1210/jendso/bvab179